Company page

Lipocine Inc.

Lipocine Inc. is a public company traded under the ticker LPCN in the American market. With a market capitalization of approximately $17.1 million, Lipocine focuses on developing innovative therapies for various medical conditions. The company is committed to advancing its product pipeline to address unmet medical needs.